Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.UK-based doctors, nurses and other healthcare professionals were given £40 million by big pharmaceutical companies in just one year, figures suggest.
Both NHS and private staff were paid the sum for consultancies and sponsorships and other interactions with drug businesses in 2012, according to the Association of the British Pharmaceutical Industry (ABPI).
The ABPI said it released the figures as part of it's "on-going transparency drive".
The money was paid to medics for "attending medical education events, support such as training and development, as well as fees for services such as speaking engagements to share good clinical practice and participation in advisory boards", a spokesman said.
In January, leaders from the medical and pharmaceutical industries announced that they are examining whether doctors who are paid by drug companies should should declare their dealings on a public register.
Disclosure of payments would be a "significant step" towards greater transparency between the industries, according to the Ethical Standards in Health and Life Sciences Group.
The working group, which includes the Royal College of Physicians (RCP) and the ABPI, launched the consultation to see whether doctors themselves should declare payments.
The ABPI added that companies also plan to show how many healthcare professionals are on their payrolls.
"The industry is proud of its collaboration with healthcare professionals," said ABPI chief executive Stephen Whitehead.
"Working closely with healthcare professionals has helped the industry to consult with, and listen to, clinical expertise and develop medicines which are in the best interest of patients.
"Full transparency about these relationships is right and appropriate and we have taken the lead to make this a reality. By publishing these figures, industry's aim is to ensure these vital relationships are open and transparent.
"It is right that professionals are reimbursed fairly for the time and expertise they regularly provide the industry in developing the next generation of medicines."
PA
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments